CGTX logo

Cognition Therapeutics (CGTX) EBIT

CGTX Annual EBIT

-$25.76 M
-$4.39 M-20.55%

31 December 2023

CGTX EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX Quarterly EBIT

-$9.93 M
-$2.90 M-41.23%

30 September 2024

CGTX Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX TTM EBIT

-$34.24 M
-$3.19 M-10.26%

30 September 2024

CGTX TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.6%-47.2%-50.2%
3 y3 years-323.1%-47.2%-50.2%
5 y5 years-574.7%-47.2%-50.2%

CGTX EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-138.0%at low-168.2%at low-216.4%at low
5 y5-year-574.7%at low-1407.1%at low-1435.5%at low
alltimeall time-574.7%at low-1407.1%at low-1435.5%at low

Cognition Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$9.93 M(+41.2%)
-$34.24 M(+10.3%)
June 2024
-
-$7.03 M(-23.0%)
-$31.05 M(+8.1%)
Mar 2024
-
-$9.14 M(+12.4%)
-$28.74 M(+11.6%)
Dec 2023
-$25.76 M(+20.6%)
-$8.13 M(+20.5%)
-$25.76 M(+13.0%)
Sept 2023
-
-$6.75 M(+42.9%)
-$22.80 M(+0.5%)
June 2023
-
-$4.72 M(-23.4%)
-$22.68 M(-4.8%)
Mar 2023
-
-$6.16 M(+19.1%)
-$23.83 M(+11.5%)
Dec 2022
-$21.37 M
-$5.17 M(-21.9%)
-$21.37 M(-9.2%)
Sept 2022
-
-$6.62 M(+12.8%)
-$23.54 M(+17.5%)
June 2022
-
-$5.87 M(+58.5%)
-$20.02 M(+31.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$3.70 M(-49.5%)
-$15.29 M(+41.2%)
Dec 2021
-$10.82 M(+77.8%)
-$7.34 M(+136.0%)
-$10.82 M(+124.5%)
Sept 2021
-
-$3.11 M(+174.5%)
-$4.82 M(+60.9%)
June 2021
-
-$1.13 M(-249.1%)
-$3.00 M(-3.3%)
Mar 2021
-
$760.00 K(-156.8%)
-$3.10 M(-49.1%)
Dec 2020
-$6.09 M(+59.5%)
-$1.34 M(+4.2%)
-$6.09 M(+28.2%)
Sept 2020
-
-$1.28 M(+4.1%)
-$4.75 M(+37.1%)
June 2020
-
-$1.23 M(-44.7%)
-$3.46 M(+55.3%)
Mar 2020
-
-$2.23 M
-$2.23 M
Dec 2019
-$3.82 M
-
-

FAQ

  • What is Cognition Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Cognition Therapeutics?
  • What is Cognition Therapeutics annual EBIT year-on-year change?
  • What is Cognition Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Cognition Therapeutics?
  • What is Cognition Therapeutics quarterly EBIT year-on-year change?
  • What is Cognition Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Cognition Therapeutics?
  • What is Cognition Therapeutics TTM EBIT year-on-year change?

What is Cognition Therapeutics annual earnings before interest & taxes?

The current annual EBIT of CGTX is -$25.76 M

What is the all time high annual EBIT for Cognition Therapeutics?

Cognition Therapeutics all-time high annual earnings before interest & taxes is -$3.74 M

What is Cognition Therapeutics annual EBIT year-on-year change?

Over the past year, CGTX annual earnings before interest & taxes has changed by -$4.39 M (-20.55%)

What is Cognition Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of CGTX is -$9.93 M

What is the all time high quarterly EBIT for Cognition Therapeutics?

Cognition Therapeutics all-time high quarterly earnings before interest & taxes is $760.00 K

What is Cognition Therapeutics quarterly EBIT year-on-year change?

Over the past year, CGTX quarterly earnings before interest & taxes has changed by -$3.19 M (-47.24%)

What is Cognition Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of CGTX is -$34.24 M

What is the all time high TTM EBIT for Cognition Therapeutics?

Cognition Therapeutics all-time high TTM earnings before interest & taxes is -$2.23 M

What is Cognition Therapeutics TTM EBIT year-on-year change?

Over the past year, CGTX TTM earnings before interest & taxes has changed by -$11.44 M (-50.17%)